Remark: Barbiturates may improve adverse effects, which include respiratory depression, produced by poisonous doses of TCAs. With therapeutic doses of TCAs, barbiturates enhance metabolism and decrease blood concentrations of TCAs.pentobarbital will lessen the extent or impact of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.